Short Implant Versus Crestal Standard Length Implant to Retain Class 1 Removable Partial Denture.
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-70
SponsorMenoufia University
About this trial
Objective: To report the implant survival rates, clinical, and radiographic outcomes of subcrestal short implant versus crestal standard length implant supported removable partial denture (RPD).
Eligibility criteria
Qualifiers
adult patients aged 50 years or older with class 1 RPD with missing mandibular molars at least and complaining from instability of the prosthesis were recruited.
Medical history revealed no contraindication to implant therapy.
Patients have an amount of bone nearly equal to 8 mm length above the inferior alveolar canal to receive a 6 mm short implant with 2 mm subcrestal to the bone level with sufficient bone width ≥ 8mm on one side and an amount of bone equal to or more than 8 mm to receive a standard-length implant of 7.5, 9, or 10.5 mm placed at crestal bone level with sufficient bone width ≥ 8mm on the contralateral side which was examined by CBCT.
Disqualifiers
Presence of active infection or inflammation in the areas intended for implant placement; *systemic diseases such as diabetes.
Pregnant and lactating patients.
Habit of severe bruxism or clenching.
Treatment with therapeutic radiation to the head within the past 12 months.
Trial design
Treatments tested in this trial
- Titanium dental implant (Conical SPI, Vitronix, Italy), Medical device that interfaces with the jawbone to support a dental prosthesis.
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
Menoufia University
Lead sponsor
Tanta University
Collaborator
Source ClinicalTrials.gov